US FDA's Streamlined Hiring Pilot Restarts After Delay
Recruiting for “Cures”-funded positions resulted in two hires, then got an HHS review; onboarding time should be reduced significantly, but finding the money to pay the higher salaries remains a challenge under the new process.
You may also be interested in...
Stephen Hahn will have over 100 stocks to divest upon becoming FDA commissioner.
The FDA is fighting to keep its authority to fill reviewer vacancies by correcting hiring irregularities.
US FDA's drug center has been hiring more employees than it has lost over the last few months and hopes the Office of New Drugs reorganization will help retention.